Project Grant R34DA061621
Award Date
9/15/24
Completion Date
7/31/27
Dollars Obligated
$239K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55454, USA
Similar Awards
This Project Grant award of $1,334,540 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports a study to optimize the delivery of pre-exposure prophylaxis (PrEP) care for underserved rural people who inject drugs (PWID) in Kentucky. The study will deploy stepped-care adaptive interventions across three rural syringe service programs (SSPs) to identify optimal intervention pathways for increasing PrEP initiation and persistence. Key...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $404,616 study titled "CHAMPION - Combining HIV and Stimulant Prevention and Treatment Interventions Optimized for HIV-Negative MSM". The study aims to (1) evaluate the feasibility and acceptability of a mobile health intervention package combining a PrEP app and virtual cognitive behavioral therapy, and (2) assess the...
This Project Grant award, valued at $2,362,500 and effective from July 1, 2025 to June 30, 2029, was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to overcome policy and regulatory barriers that hinder access to evidence-based harm reduction and treatment services for preventing HIV transmission and overdose among people who use drugs. Key deliverables include: 1) a tool to identify policy...
This Project Grant award of $1,681,276 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to identify preferences and care components to optimize the delivery of long-acting injectable (LAI) PrEP for sexual minority men (SMM) who use methamphetamine in the U.S. The study will leverage an existing cohort to first conduct qualitative interviews with SMM who use methamphetamine and healthcare providers, then...
The National Institute on Drug Abuse (NIDA) awarded a $1,932,699 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Maryland, Baltimore. The grant, effective August 1, 2024 through May 31, 2025, will fund a randomized trial to evaluate the effectiveness and implementation of a peer-delivered behavioral activation and problem-solving intervention, "Peer Activate-LAI," for improving adherence to long-acting injectable (LAI) HIV...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an evidence-based quality improvement...
This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
This federal Project Grant award of $146,922 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to identify patient-level implementation determinants related to long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young men who have sex with men (YMSM) living in rural areas. The award will fund a convergent mixed methods study conducted by the Medical College of Wisconsin, Inc. to understand rural YMSM's...